Showing results (91-100 of 385) with videos related to
Sort By:
Pageof 39
Journal of Virus Eradication|July 13, 2023
Antigen specificities of HIV-infected cells: A role in infection and persistence?Clayton Faua, Samira Fafi-Kremer, Pierre GantnerJournal of Virus Eradication|July 6, 2023
Rate of occult hepatitis B virus infection among individuals with tuberculosis in northeastern Iran: A molecular epidemiological studySanaz Ahmadi Ghezeldasht, Saman Soleimanpour, Mohammad Reza Hedayati-Moghaddam, et al.Journal of Virus Eradication|September 29, 2023
The central nervous system is a potential reservoir and possible origin of drug resistance in hepatitis B infectionLijun Xu, Minghan Zhou, Xiuming Peng, et al.Journal of Virus Eradication|April 24, 2018
Tenofovir alafenamide versus tenofovir disoproxil fumarate: is there a true difference in efficacy and safety?Andrew Hill, Sophie L Hughes, Dzintars Gotham, et al.Journal of Virus Eradication|June 19, 2026
Antiviral efficacy of LNP-delivered IFN-α14-ApoAI mRNA for chronic hepatitis BQunling Yang, Qiang Li, Jie Cao, et al.Journal of Virus Eradication|February 26, 2019
Stability of plasma indices of inflammation/coagulation and homeostasis after fatty and non-fatty meals in treated people with HIVDominic Dorazio, Douglas W Kitch, Netanya S Utay, et al.Journal of Virus Eradication|February 26, 2019
Highlights from the Fourth Biennial Strategies for an HIV Cure Meeting, 10-12 October 2018, Bethesda, MD, USALillian Kuo, Diane Lawrence, David McDonald, et al.Journal of Virus Eradication|January 25, 2021
Achievements and gaps to provide pre-exposure prophylaxis (PrEP) for women across the European Region - Results from a European survey studyEllen Moseholm, Yvonne Gilleece, Ben Collins, et al.Journal of Virus Eradication|April 25, 2017
The complex legal and ethical issues related to generic medications. Viral hepatitis: a case studyM Danta, N GhineaPageof 39